These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7306945)

  • 1. Effect of the pretreatment with disulfiram on the toxicity and antitumor activity of 1-(2-hydroxyethyl)-3-(2-chloroethyl)-3-nitrosourea in Sprague--Dawley rats.
    Habs H; Habs M
    Cancer Lett; 1981 Jun; 13(1):63-9. PubMed ID: 7306945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
    Habs M; Reinbold H; Eisenbrand G; Bhide S; Goga-Ionescu S; Schmähl D
    J Cancer Res Clin Oncol; 1981; 101(3):285-302. PubMed ID: 7309781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
    Bhide S; Habs M; Reinbold H; Schmähl D
    J Cancer Res Clin Oncol; 1979 May; 94(1):63-7. PubMed ID: 468900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
    Eisenbrand G
    IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain uptake and CNS levels of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)urea (HECNU).
    Unger C; Eibl H; Engel J; Nagel GA; Eisenbrand G
    Invest New Drugs; 1987 Dec; 5(4):361-4. PubMed ID: 3436741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
    Akaike Y; Arai Y; Taguchi H; Satoh H
    Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)urea linked to 4-acetoxy-bisdesmethyltamoxifen, estradiol and dihydrotestosterone.
    Kaleagasioglu F; Berger MR; Schmähl D; Eisenbrand G
    Arzneimittelforschung; 1990 May; 40(5):603-6. PubMed ID: 2383304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pretreatment with disulfiram (DSF) on the acute toxicity of cyclophosphamide (CP) in male Sprague-Dawley rats.
    Habs H; Habs M; Schmähl D
    Arzneimittelforschung; 1981; 31(3):530-1. PubMed ID: 7194679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and clinical studies of the antitumor activity of 1-methyl-1-nitrosourea (NSC-23909).
    Emanuel NM; Vermel EM; Ostrovskaya LA; Korman NP
    Cancer Chemother Rep; 1974; 58(2):135-48. PubMed ID: 4830495
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of DNA damage in various tissues, myelosuppression and serum levels of transaminases and bilirubin in tumor-bearing female Sprague-Dawley rats treated with 1-(2-hydroxyethyl)-3-(2-chloroethyl)-3-nitrosourea (HECNU).
    Henne T; Berger MR
    J Cancer Res Clin Oncol; 1986; 111(1):75-8. PubMed ID: 3949853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of malignant recurrent glioma by intra-arterial, infra-ophthalmic infusion of HECNU 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl) urea. A phase II study.
    Poisson M; Chiras J; Fauchon F; Debussche C; Delattre JY
    J Neurooncol; 1990 Jun; 8(3):255-62. PubMed ID: 2193122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of nicotine with anticancer treatment.
    Berger MR; Zeller WJ
    Klin Wochenschr; 1988; 66 Suppl 11():127-33. PubMed ID: 3184771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between DNA damage and the inhibition of stem cells in murine bone marrow after single and repeated administration of BCNU and HECNU.
    Berger MR; Henne T; Bedford P
    J Cancer Res Clin Oncol; 1985; 110(3):185-90. PubMed ID: 4077917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.
    Bedford P; Berger MR; Eisenbrand G; Schmähl D
    J Cancer Res Clin Oncol; 1984; 108(1):141-7. PubMed ID: 6235230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET studies of potential chemotherapeutic agents--X. Synthesis of "no-carrier-added" (11C)-HECNU: the hydroxyethyl analog of the chemotherapeutic agent BCNU.
    Conway T; Diksic M
    Int J Rad Appl Instrum A; 1991; 42(5):441-6. PubMed ID: 1646189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
    Inoue K; Fujimoto S; Ogawa M
    Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
    Fujimoto S; Tashiro T; Ogawa M
    Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity of hydroxylated chloroethylnitrosoureas.
    Zeller WJ; Frühauf S; Chen G; Eisenbrand G; Lijinsky W
    Cancer Res; 1989 Jun; 49(12):3267-70. PubMed ID: 2720679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human glutathione reductase by the nitrosourea drugs 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea. A crystallographic analysis.
    Karplus PA; Krauth-Siegel RL; Schirmer RH; Schulz GE
    Eur J Biochem; 1988 Jan; 171(1-2):193-8. PubMed ID: 3338461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies of reducing the carcinogenic risk of cytostatic agents on the basis of bioassay evaluation.
    Berger MR
    Neoplasma; 1991; 38(4):369-78. PubMed ID: 1922569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.